查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571685

北美家庭医疗保健市场规模、份额、趋势分析报告：按组成部分、按适应症、按地区、细分市场预测，2024-2030 年

North America Home Healthcare Market Size, Share & Trends Analysis Report By Component (Equipment, Services), By Indication (Cardiovascular Disorder & Hypertension, Cancer), By Region And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格
简介目录

北美家庭医疗保健市场的成长与趋势：

Grand View Research, Inc.最新报告显示，2030年北美家庭医疗保健市场规模预计将达到2,850.5亿美元，2024年至2030年复合年增长率为7.7%。

推动成长的主要因素包括人口老化、可用于医疗保健支出的高水平可支配收入以及越来越多的目标疾病。慢性病占主导地位，诊断成本上升预计将推动成长。

个人化医疗援助是控制治疗成本的一种经济有效的手段，也是该产业的关键驱动力。根据美国健康排名，到 2022 年，美国将有大约 5,800 万 65 岁及以上的成年人居住。

预计家庭医疗保健产业将在很大程度上受到大量老龄化人口的推动，这些人口容易患上各种疾病，例如静脉淤滞性溃疡、糖尿病性溃疡和压疮。根据世界卫生组织统计，2014年全球60岁以上人口数达8.41亿，预计2050年将达20亿。因此，全球老化速度不断加快，据统计，约70%的家庭医疗患者属于65岁及以上年龄组，预计在不久的将来推动需求。

2014年创伤护理占全球市场收益的65%。对伤口缝合材料、创伤护理敷料和伤口清洗的巨大需求导致了过去几年该领域的主导地位，预计这种趋势在预测期内将持续下去。由于伤口感染是医护人员和患者的关键安全问题，预计市场将受到感染率下降的推动，从而推动需求。创伤护理产品可改善患有糖尿病溃疡、压疮和静脉瘀血性溃疡等各种疾病的患者的整体健康状况，从而在行业中产生了对这些产品的强烈需求。

由于个人安全和卫生意识的提高，老年患者数量的增加预计将进一步增加北美对家庭医疗保健服务的需求。百特提供广泛的解决方案，为医疗保健专业人员提供个人化照护。我们为医疗保健专业人员提供产品，包括医院护理、基层医疗、肾臟护理、外科护理和营养护理。

2023年，服务业的市场占有率最大，达84.1%。此细分市场进一步分为熟练家庭护理和非熟练家庭护理。家庭医疗保健服务提供多种服务，包括营养支持、护理、临终关怀和安宁疗护以及医生的基层医疗。熟练的医疗保健人员提供的准确诊断和治疗有助于该细分市场的成长。同时，设备产业预计在预测期内复合年增长率为8.6%。此部分分为治疗、诊断和行动辅助部分。

由于其先进的医疗保健基础设施，美国家庭医疗保健市场在 2023 年以 90.0% 的份额主导北美市场。推动成长的主要因素包括人口老化、不断发展的医疗基础设施和高购买力。此外，旨在透过促进家庭护理服务来控制治疗成本的政府措施预计将支持成长。根据人口研究所 (PRB) 的数据，北美 65 岁及以上人口目前约为 5,000 万，预计到 2050 年将达到 8,900 万。

北美家庭医疗保健市场报告亮点

  • 2023年，服务业将拥有最大的市场占有率，达到84.1%。此细分市场进一步分为熟练家庭护理和非熟练家庭护理。
  • 预计设备产业在预测期内的复合年增长率将达到 8.6%，是最快的。此部分分为治疗、诊断和行动辅助部分。
  • 2023年，糖尿病/肾臟疾病领域将占据最大的市场占有率。据美国糖尿病协会称，2021 年有 3,840 万美国被诊断出患有糖尿病。
  • 预计行动障碍市场在预测期内将以最快的复合年增长率成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章北美家庭医疗保健市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 北美家庭医疗保健市场分析工具
    • 波特的分析
    • PESTEL分析

第四章北美家庭医疗保健市场：成分估计与趋势分析

  • 细分仪表板
  • 北美家庭医疗保健市场：2023 年和 2030 年成分变化分析
  • 装置
  • 服务

第五章 北美家庭医疗保健市场：指标估算与趋势分析

  • 细分仪表板
  • 北美家庭医疗保健市场：2023 年和 2030 年适应症变化分析
  • 心血管疾病与高血压
  • 糖尿病和肾臟疾病
  • 神经和精神疾病
  • 呼吸系统疾病与慢性阻塞性肺病
  • 母体疾病
  • 运动障碍
  • 癌症
  • 创伤护理
  • 其他的

第六章北美家庭医疗保健市场：区域估计和趋势分析

  • 2023 年及 2030 年北美家庭医疗保健市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • B. Braun SE
    • Abbott
    • Sunrise Medical
    • 3M
    • Baxter
    • Medtronic
    • Cardinal Health
    • F. Hoffmann-La Roche Ltd
    • Amedisys
    • ARKRAY, Inc.
    • BD
    • OMRON Healthcare, Inc.
    • GE Healthcare
    • Medline Industries, Inc
    • Koninklijke Philips NV
    • Johnson &Johnson Services, Inc.
    • Acelity（3M）
    • Teleflex Incorporated.
    • Fresenius Kabi AG.
    • Bayer AG
    • GF Health Products, Inc.
    • Knight Health Holdings, LLC
    • NHC, National Healthcare Corporation
    • Gentiva
    • Medco Home Healthcare, Inc.
    • Brookdale Senior Living Inc.
    • Sunrise Senior Living
    • Genesis HealthCare
    • EXTENDICARE.
    • Diversicare.
    • Home Instead, Inc.
    • Senior Services of America
    • Atria Senior Living, Inc
简介目录
Product Code: 978-1-68038-607-3

North America Home Healthcare Market Growth & Trends:

The North America home healthcare market size is expected to reach USD 285.05 billion by 2030, registering a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising aging human population, high disposable income for healthcare expenditure, and increasing rate of target diseases are some of the key factors driving growth. Predominance of chronic diseases, and increasing diagnosis expenditure is anticipated to boost growth.

Personalized medical assistance is a cost effective measure to control treatment expenditure and acts as a major driver for the industry. According to America's Health rankings, nearly 58 million adults aged 65 and older lived in the U.S. in 2022.

The home healthcare industry is anticipated to be majorly driven by the huge aging population volume which is highly prone to various diseases such as venous stasis ulcers, diabetic ulcers, and pressure ulcers. According to WHO, the global volume of population falls under the age group of 60 years and above has reached 841 million in 2014 and is expected to reach 2 billion by 2050. Therefore, rising global aging-population along with the statistics that approximately 70% of home healthcare patients belong to 65 years and above age group, is anticipated to fuel demand in the near future.

Wound care accounted for 65% of the global market revenue in 2014. Substantial demand for wound closures, wound care dressings, and wound cleanser has resulted in the dominance of the segment over the past few years and this trend is expected to continue over the forecast period. Wound infection is a key safety concern for medical professionals and patients, thus the market is anticipated to fuel the demand as it compelled to reduce the infection rates. Wound care products improve the overall health of patients affected from various disorders such as, diabetic ulcers, pressure ulcers and venous stasis ulcers, therefore creating strong need for these products in the industry.

Rising number of geriatric patients with growing awareness about personal safety and hygiene is further expected to intensify home healthcare service demand in North America. Baxter offers broad solutions to empower healthcare professionals to offer personalized care. It offers products for healthcare professionals for hospital care, primary care, kidney care, surgical care, nutritional care and others.

The services segment accounted for the largest market share of 84.1% in 2023. The segment is further divided into skilled and unskilled homecare. Different services such as nutritional support, nursing care, hospice & palliative, physician primary care, and others are offered by home healthcare services. The accurate diagnosis and medical treatment offered by skilled healthcare is attributing the segment growth. On the other hand, the equipment segment is expected to register the fastest CAGR of 8.6% during the forecast period. The segment is divided into therapeutic, diagnostic, and mobility assist segments.

The U.S. home healthcare market dominated the North America market with a share of 90.0% in 2023 due to advanced healthcare infrastructure. Large base of aging population, growing healthcare infrastructure and high purchasing power are some of the key factors driving growth. Moreover, favorable government initiatives aimed at controlling treatment expenditure by promoting home care services are anticipated to fuel growth. According to the PRB (Population Reference Bureau), at present, approximately 50 million citizens of North America are over 65 years and the number is projected to reach 89 million by 2050.

North America Home Healthcare Market Report Highlights:

  • The services segment accounted for the largest market share of 84.1% in 2023. The segment is further divided into skilled and unskilled homecare.
  • The equipment segment is expected to register the fastest CAGR of 8.6% during the forecast period. The segment is divided into therapeutic, diagnostic, and mobility assist segments.
  • The diabetes & kidney disorders segment accounted for the largest market share in 2023. According to American Diabetes Association, 38.4 million Americans were diagnosed with diabetes in 2021.
  • The mobility disorders segment is projected to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America Home Healthcare Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. North America Home Healthcare Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. North America Home Healthcare Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America Home Healthcare Market: Component Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Equipment
    • 4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Therapeutic
      • 4.3.2.1. Therapeutic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.1. Home Respiratory Equipment
          • 4.3.2.1.1.1. Home Respiratory Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.2. Insulin Delivery Market
          • 4.3.2.1.2.1. Insulin Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.3. Home IV Pumps
          • 4.3.2.1.3.1. Home IV Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.4. Home Dialysis Equipment
          • 4.3.2.1.4.1. Home Dialysis Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.5. Other Therapeutic Equipment
          • 4.3.2.1.5.1. Other Therapeutic Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Diagnostic
      • 4.3.3.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.1. Diabetic Care Unit
          • 4.3.3.1.1.1. Diabetic Care Unit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.2. BP Monitors
          • 4.3.3.1.2.1. BP Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.3. Multi Para Diagnostic Monitors
          • 4.3.3.1.3.1. Multi Para Diagnostic Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.4. Home Pregnancy and Fertility Kits
          • 4.3.3.1.4.1. Home Pregnancy and Fertility Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.5. Apnea and Sleep Monitors
          • 4.3.3.1.5.1. Apnea and Sleep Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.6. Holter Monitors
          • 4.3.3.1.6.1. Holter Monitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.7. Heart Rate Meters (include pacemakers)
          • 4.3.3.1.7.1. Heart Rate Meters (include pacemakers) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.3.1.8. Others
          • 4.3.3.1.8.1. Other Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Mobility Assist
      • 4.3.4.1. Mobility Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.1. Wheel Chair
          • 4.3.4.1.1.1. Wheel Chair Assist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.2. Home Medical Furniture
          • 4.3.4.1.2.1. Home Medical Furniture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.3.4.1.3. Walking Assist Devices
          • 4.3.4.1.3.1. Walking Assist Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Skilled Home Healthcare
      • 4.4.2.1. Skilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.1. Physician Primary Care
          • 4.4.2.1.1.1. Physician Primary Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.2. Nursing Care
          • 4.4.2.1.2.1. Nursing Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.3. Physical/Occupational/Speech Therapy
          • 4.4.2.1.3.1. Physical/Occupational/Speech Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.4. Nutritional Support
          • 4.4.2.1.4.1. Nutritional Support Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.5. Hospice & Palliative
          • 4.4.2.1.5.1. Hospice & Palliative Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.4.2.1.6. Other Skilled Nursing Services
          • 4.4.2.1.6.1. Other Skilled Nursing Se Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Unskilled Home Healthcare
      • 4.4.3.1. Unskilled Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America Home Healthcare Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America Home Healthcare Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Cardiovascular Disorder & Hypertension
    • 5.3.1. Cardiovascular Disorder & Hypertension Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Diabetes & Kidney Disorders
    • 5.4.1. Equipment Identification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Neurological & Mental Disorders
    • 5.5.1. Neurological & Mental Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Respiratory Diseases & COPD
    • 5.6.1. Respiratory Diseases & COPD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Maternal Disorders
    • 5.7.1. Maternal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Mobility Disorders
    • 5.8.1. Mobility Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Cancer
    • 5.9.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Wound Care
    • 5.10.1. Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Other Indications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America Home Healthcare Market: Regional Estimates & Trend Analysis

  • 6.1. North America Home Healthcare Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico North America Home Healthcare Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. B. Braun SE
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Abbott
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Sunrise Medical
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. 3M
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Baxter
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Medtronic
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Cardinal Health
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. F. Hoffmann-La Roche Ltd
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Amedisys
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. ARKRAY, Inc.
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. BD
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. OMRON Healthcare, Inc.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. GE Healthcare
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives
    • 7.4.14. Medline Industries, Inc
      • 7.4.14.1. Participant's Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Recent Developments/ Strategic Initiatives
    • 7.4.15. Koninklijke Philips N.V.
      • 7.4.15.1. Participant's Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Recent Developments/ Strategic Initiatives
    • 7.4.16. Johnson & Johnson Services, Inc.
      • 7.4.16.1. Participant's Overview
      • 7.4.16.2. Financial Performance
      • 7.4.16.3. Product Benchmarking
      • 7.4.16.4. Recent Developments/ Strategic Initiatives
    • 7.4.17. Acelity (3M)
      • 7.4.17.1. Participant's Overview
      • 7.4.17.2. Financial Performance
      • 7.4.17.3. Product Benchmarking
      • 7.4.17.4. Recent Developments/ Strategic Initiatives
    • 7.4.18. Teleflex Incorporated.
      • 7.4.18.1. Participant's Overview
      • 7.4.18.2. Financial Performance
      • 7.4.18.3. Product Benchmarking
      • 7.4.18.4. Recent Developments/ Strategic Initiatives
    • 7.4.19. Fresenius Kabi AG.
      • 7.4.19.1. Participant's Overview
      • 7.4.19.2. Financial Performance
      • 7.4.19.3. Product Benchmarking
      • 7.4.19.4. Recent Developments/ Strategic Initiatives
    • 7.4.20. Bayer AG
      • 7.4.20.1. Participant's Overview
      • 7.4.20.2. Financial Performance
      • 7.4.20.3. Product Benchmarking
      • 7.4.20.4. Recent Developments/ Strategic Initiatives
    • 7.4.21. GF Health Products, Inc.
      • 7.4.21.1. Participant's Overview
      • 7.4.21.2. Financial Performance
      • 7.4.21.3. Product Benchmarking
      • 7.4.21.4. Recent Developments/ Strategic Initiatives
    • 7.4.22. Knight Health Holdings, LLC
      • 7.4.22.1. Participant's Overview
      • 7.4.22.2. Financial Performance
      • 7.4.22.3. Product Benchmarking
      • 7.4.22.4. Recent Developments/ Strategic Initiatives
    • 7.4.23. NHC, National Healthcare Corporation
      • 7.4.23.1. Participant's Overview
      • 7.4.23.2. Financial Performance
      • 7.4.23.3. Product Benchmarking
      • 7.4.23.4. Recent Developments/ Strategic Initiatives
    • 7.4.24. Gentiva
      • 7.4.24.1. Participant's Overview
      • 7.4.24.2. Financial Performance
      • 7.4.24.3. Product Benchmarking
      • 7.4.24.4. Recent Developments/ Strategic Initiatives
    • 7.4.25. Medco Home Healthcare, Inc.
      • 7.4.25.1. Participant's Overview
      • 7.4.25.2. Financial Performance
      • 7.4.25.3. Product Benchmarking
      • 7.4.25.4. Recent Developments/ Strategic Initiatives
    • 7.4.26. Brookdale Senior Living Inc.
      • 7.4.26.1. Participant's Overview
      • 7.4.26.2. Financial Performance
      • 7.4.26.3. Product Benchmarking
      • 7.4.26.4. Recent Developments/ Strategic Initiatives
    • 7.4.27. Sunrise Senior Living
      • 7.4.27.1. Participant's Overview
      • 7.4.27.2. Financial Performance
      • 7.4.27.3. Product Benchmarking
      • 7.4.27.4. Recent Developments/ Strategic Initiatives
    • 7.4.28. Genesis HealthCare
      • 7.4.28.1. Participant's Overview
      • 7.4.28.2. Financial Performance
      • 7.4.28.3. Product Benchmarking
      • 7.4.28.4. Recent Developments/ Strategic Initiatives
    • 7.4.29. EXTENDICARE.
      • 7.4.29.1. Participant's Overview
      • 7.4.29.2. Financial Performance
      • 7.4.29.3. Product Benchmarking
      • 7.4.29.4. Recent Developments/ Strategic Initiatives
    • 7.4.30. Diversicare.
      • 7.4.30.1. Participant's Overview
      • 7.4.30.2. Financial Performance
      • 7.4.30.3. Product Benchmarking
      • 7.4.30.4. Recent Developments/ Strategic Initiatives
    • 7.4.31. Home Instead, Inc.
      • 7.4.31.1. Participant's Overview
      • 7.4.31.2. Financial Performance
      • 7.4.31.3. Product Benchmarking
      • 7.4.31.4. Recent Developments/ Strategic Initiatives
    • 7.4.32. Senior Services of America
      • 7.4.32.1. Participant's Overview
      • 7.4.32.2. Financial Performance
      • 7.4.32.3. Product Benchmarking
      • 7.4.32.4. Recent Developments/ Strategic Initiatives
    • 7.4.33. Atria Senior Living, Inc
      • 7.4.33.1. Participant's Overview
      • 7.4.33.2. Financial Performance
      • 7.4.33.3. Product Benchmarking
      • 7.4.33.4. Recent Developments/ Strategic Initiatives